Reuters logo
BRIEF-1nkemia licences results of food supplements project to Myogem
January 5, 2017 / 6:58 AM / 9 months ago

BRIEF-1nkemia licences results of food supplements project to Myogem

Jan 5 (Reuters) - 1nkemia IUCT Group S.A. :

* Said on Wednesday that it has agreed to license discoveries of its food supplements project ‘MYO-DM1’ to its unit Myogem Health Company S.L. after positive results

* With this license it is expected that Myogem will soon put on the market a product focused on improving the health of people affected by myotonic dystrophy type 1 (DM1), based on licensed discoveries

Source text: bit.ly/2j6VYUz

Further company coverage:

Gdynia Newsroom

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below